The recent emergence of nanomedicine has revolutionized the therapeutic landscape and
necessitated the creation of more sophisticated drug delivery systems. Polymeric …

Nanoscale engineering is one of the innovative approaches to heal multitudes of ailments,
such as varieties of malignancies, neurological problems, and infectious illnesses …

The brain–gut–microbiome axis is a bidirectional communication pathway between the gut
microbiota and the central nervous system. The growing interest in the gut microbiota and …

The blood–brain barrier (BBB) is a vital boundary between neural tissue and circulating
blood. The BBB's unique and protective features control brain homeostasis as well as ion …

Transition‐metal dyshomeostasis is recognized as a critical pathogenic factor at the onset
and progression of neurodegenerative disorder (ND). Excess transition‐metal ions such as …

Purpose Poly (lactic-co-glycolic acid) has received much academic attention for develo**
nanotherapeutics and FDA has approved it for several applications. An important parameter …

Transition‐metal dyshomeostasis has been identified as a critical pathogenic factor for the
aggregates of amyloid‐beta (Aβ) peptide, which is associated with the onset and …

Somatostatin (SST) is a well-known neuropeptide that is expressed throughout the brain. In
the cortex, SST is expressed in a subset of GABAergic neurons and is known as a protein …

Effective therapy lies in achieving a therapeutic amount of drug to the proper site in the body
and then maintaining the desired drug concentration for a sufficient time interval to be …

Parkinson's disease (PD) is a progressive and chronic neurodegenerative disease of the
central nervous system. Early treatment for PD is efficient; however, long-term systemic …